IMpower010: Results From Asian Patients in a Phase 3 Study of Adjuvant Atezolizumab in Resected Stage IB-IIIA NSCLC
IMpower010: Results From Asian Patients in a Phase 3 Study of Adjuvant Atezolizumab in Resected Stage IB-IIIA NSCLC
复制标题
IMpower010：Atezolizumab 辅助治疗切除的 IB-IIIA 期 NSCLC 3 期研究中来自亚洲患者的结果
DOI：
--
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Hirotsugu Kenmotsu,1 Caicun Zhou,2 Nasser Altorki,3 Enriqueta Felip,4 Eric Vallieres,5 Shunichi Sugawara,6 Hiroshi Sakai,7 Haruhiro Saito,8 Min Tao,9 Koji Kawaguchi,10 Yunpeng Liu,11 Chong-Jen Yu,12 Qiong Wu,13 Huang Lin,13 Fan Wu,13 Elizabeth Bennett,
中科院分区：
文献类型：
--
作者：
Mitsunori Higuchi;Takeshi Nagata;Junzo Suzuki;Takashi Yabuki;Sho Inomata;and Hiroyuki Suzuki;Hirotsugu Kenmotsu,1 Caicun Zhou,2 Nasser Altorki,3 Enriqueta Felip,4 Eric Vallieres,5 Shunichi Sugawara,6 Hiroshi Sakai,7 Haruhiro Saito,8 Min Tao,9 Koji Kawaguchi,10 Yunpeng Liu,11 Chong-Jen Yu,12 Qiong Wu,13 Huang Lin,13 Fan Wu,13 Elizabeth Bennett,
